CRS: JHU
Position: CTU Leader for HPTN Studies
CRS: BJMC
Position: Lab Manager
Position: Research Clinician
Position: Study Coordinator
Position: Clinical Coordinator
Position: CRS Coordinator
We will address our hypothesis using a case-control study design. We plan to leverage the existing biorepository of...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
Rifampin (RIF), the cornerstone of TB treatment, has very problematic drug-drug interactions with PIs. The use of relatively...
IMPAACT P1026s, the predecessor of this study, was first approved in 2003. P1026s enrolled over 1000 pregnant/postpartum women,...
Efavirenz (EFV) is an anti-HIV medicine that is commonly used to treat HIV infection in adults and children older than 3 years...
